Pharmaceuticals Inc. specializes in developing oncology and dermatology therapies. Its novel oncology drug, PV-10, is designed to selectively target and destroy cancer cells without harming surrounding healthy tissue, significantly reducing potential for systemic side effects. Its oncology focus is on melanoma, breast cancer, and cancers of the liver. PVCT has received orphan drug designations from the FDA for its melanoma and hepatocellular carcinoma indications. For more information, visit the company’s Web site at: www.pvct.com

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its ninth annual equity conference at The Hard Rock Hotel in Ft. Lauderdale, FL. Attended by institutional investors from across North America, the event features 135 public company executive teams with an emphasis on healthcare, technology, defense, and new-media / entertainment sectors.

Let us hear your thoughts below: